Larry Dobrow

Most Recent Articles by Larry Dobrow

Patient Education/Marketing Report: Revolution

Patient Education/Marketing Report: Revolution

Patient education used to be a cookie-cutter operation: Hire a spokesperson, plan an event and draft a static list of symptoms, then call it a day. But in the wake of groundbreaking campaigns from AstraZeneca and Novartis, the industry may well have to raise its content-creation game—and cede considerable control to super-informed patients in the process. Larry Dobrow reports on the two programs that have raised the ­ patient-ed stakes

Headliner: Sales vet keeps 111-year-old title spry

Headliner: Sales vet keeps 111-year-old title spry

Amy Clarke Luchsinger "thinks that HCPs want both digital and print. The people [she] talks with just want to be able to access information when and where they want it . . .

Biotech Report: Will Gene Therapy Go Mainstream?

Biotech Report: Will Gene Therapy Go Mainstream?

The products are safe. The science is rock-solid. Patients are champing at the bit. But as much as the industry may be lining up behind gene therapies, marketing and operational questions abound. Larry Dobrow reports on the current state of the gene therapy union

Headliner: Silk smooths Takeda myeloma shift

Headliner: Silk smooths Takeda myeloma shift

He didn't want to just invest in a winning horse—he wanted to help groom it

Top 100 Agencies 2015: STRIKEFORCE Communications

Top 100 Agencies 2015: STRIKEFORCE Communications

A smaller agency thinks and acts big

More Articles by Larry Dobrow


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.